tirzepatide discontinuation GLP-1 receptor agonists and tirzepatide have transformed obesity and type 2 diabetes care. But the next major challenge is becoming clear: durable metabolic maintenance. A recent Nature Reviews…-mvanhaasteren.nl Tirzepatide for maintenance of bodyweight
Description
HENSCHKE, Mark
00656-2/asset/38c98550-9ec2-44e8-ba6a-dbb815075666/main.assets/gr1_lrg.jpg)
Prescribed by specialists at Aayu Well.

90% (n=225) of patients were female, with an average age of 41.312 years
Wyniki: Uczestnicy wykazali znaczn utrat masy ciaa
